Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Discuss risks and benefits with your healthcare provider
V.Wewer AlbrechtsenN
These are typically foreign-body granulomas
Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector
US$ 26.76
US$ 25.31
US$ 28.24
